| 1001 | Liver volume | GCST90016666 | 17.94 |
| 1002 | CA3/HMBS ratio | GCST90313584 | 17.90 |
| 1003 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T121 | ECGU000121 | 17.89 |
| 1004 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T49 | ECGU000049 | 17.87 |
| 1005 | LRP11 levels | GCST90469796 | 17.87 |
| 1006 | Cholesterol to total lipids ratio in very small VLDL | GCST90093029 | 17.86 |
| 1007 | LPL levels | GCST90469788 | 17.85 |
| 1008 | aparc-Desikan rh volume insula | GCST90002834 | 17.83 |
| 1009 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T62 | ECGU000062 | 17.80 |
| 1010 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T54 | ECGA000054 | 17.80 |
| 1011 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T358 | ECGU000358 | 17.80 |
| 1012 | IDP dMRI ProbtrackX L3 str r | GCST90004324 | 17.75 |
| 1013 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T324 | ECGU000324 | 17.70 |
| 1014 | Insomnia (standard GWA) | GCST90267286 | 17.70 |
| 1015 | Dried fruit liking | GCST90094756 | 17.69 |
| 1016 | TNC levels | GCST90470895 | 17.68 |
| 1017 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T145 | ECGA000145 | 17.65 |
| 1018 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T34 | ECGA000034 | 17.64 |
| 1019 | Triglycerides x low social support interaction (2df test) | GCST90570681 | 17.64 |
| 1020 | Cholesteryl esters to total lipids ratio in very small VLDL | GCST90093031 | 17.62 |
| 1021 | Triglyceride levels in small VLDL | GCST90132667 | 17.60 |
| 1022 | QC T1-to-standard linear alignment discrepancy | GCST90006345 | 17.59 |
| 1023 | Artrosis, including avohilmo | FING00000112 | 17.58 |
| 1024 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T171 | ECGA000171 | 17.57 |
| 1025 | Volume of left medial nucleus | GCST90474976 | 17.54 |
| 1026 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T39 | ECGA000039 | 17.51 |
| 1027 | HippSubfield rh volume CA3-body | GCST90002702 | 17.45 |
| 1028 | T1 CAT volume R SupramarginalGyrusanteriordivision | GCST90384037 | 17.44 |
| 1029 | Unruptured cerebral aneurysm | GCST90018596 | 17.44 |
| 1030 | aseg rh intensity Lateral-Ventricle | GCST90003778 | 17.43 |
| 1031 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 16) | GCST90320579 | 17.41 |
| 1032 | Myocardial infarction (PheCode 411.2) | GCST90475932 | 17.36 |
| 1033 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T107 | ECGU000107 | 17.33 |
| 1034 | DTI TBSS L3 External capsule L | GCST90384557 | 17.33 |
| 1035 | IDP dMRI ProbtrackX MO str r | GCST90004024 | 17.32 |
| 1036 | Participation in an health questionnaire (not invited vs invited) | GCST90012794 | 17.31 |
| 1037 | Testicular hypofunction (PheCode 257.1) | GCST90475697 | 17.31 |
| 1038 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T357 | ECGU000357 | 17.31 |
| 1039 | BST2/MME ratio | GCST90313539 | 17.29 |
| 1040 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T66 | ECGU000066 | 17.28 |
| 1041 | IDP dMRI TBSS L1 Uncinate fasciculus L | GCST90004120 | 17.28 |
| 1042 | IDP dMRI TBSS MD Uncinate fasciculus R | GCST90004071 | 17.24 |
| 1043 | Number of incorrect matches in round | Pairs matching | UKBB00000538 | 17.24 |
| 1044 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T310 | ECGA000310 | 17.23 |
| 1045 | Bone marrow fat fraction of lumbar vertebra 5 | GCST90652390 | 17.22 |
| 1046 | Stroke, excluding SAH | FING00001337 | 17.22 |
| 1047 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T126 | ECGA000126 | 17.20 |
| 1048 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T56 | ECGA000056 | 17.17 |
| 1049 | Father's age | Family history | UKBB00000240 | 17.15 |
| 1050 | Left-hemisphere salience/ventral attention network to left-hemisphere control network white-matter structural connectivity | GCST90302710 | 17.14 |
| 1051 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T267 | ECGA000267 | 17.13 |
| 1052 | Abdominal aortic aneurysm (PheCode 442.11) | GCST90475994 | 17.13 |
| 1053 | Volume of right whole amygdala | GCST90474931 | 17.12 |
| 1054 | Nonrheumatic aortic valve disorders (PheCode 395.2) | GCST90475914 | 17.12 |
| 1055 | Left-hemisphere control network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302748 | 17.11 |
| 1056 | Nonalcoholic fatty liver disease | GCST90054782 | 17.11 |
| 1057 | aparc-DKTatlas lh area pericalcarine | GCST90003253 | 17.10 |
| 1058 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T142 | ECGU000142 | 17.09 |
| 1059 | Coronary artery / coronary heart disease (including heart attack, angina) | GCST90475198 | 17.09 |
| 1060 | Barrett's esophagus | GCST003738 | 17.08 |
| 1061 | Central pulse pressure | GCST90267387 | 17.07 |
| 1062 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T76 | ECGU000076 | 17.07 |
| 1063 | Creatinine (enzymatic) in urine | Urine assays | UKBB00000155 | 17.05 |
| 1064 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T168 | ECGA000168 | 17.03 |
| 1065 | EIF1AX levels | GCST90241120 | 17.03 |
| 1066 | T1 FreeSurfer DK rh lateraloccipital volume | GCST90385767 | 17.01 |
| 1067 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T428 | ECGA000428 | 17.01 |
| 1068 | Diastolic blood pressure | GCST90301698 | 17.00 |
| 1069 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T216 | ECGU000216 | 16.98 |
| 1070 | Early lumbar disc prolapse, operated | FING00000484 | 16.96 |
| 1071 | Remnant cholesterol (non-HDL, non-LDL -cholesterol) | GCST90499335 | 16.96 |
| 1072 | NAAA/SMPD1 ratio | GCST90315510 | 16.95 |
| 1073 | BPIFB2 levels | GCST90468463 | 16.95 |
| 1074 | Familial combined hyperlipidemia defined by Dutch criteria | GCST90104005 | 16.94 |
| 1075 | ACY1/SCLY ratio | GCST90313165 | 16.94 |
| 1076 | IDP dMRI TBSS MD Sagittal stratum L | GCST90004058 | 16.92 |
| 1077 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T42 | ECGA000042 | 16.91 |
| 1078 | IDP dMRI TBSS FA External capsule L | GCST90003910 | 16.89 |
| 1079 | Principal component-derived dietary pattern 43 | GCST90133048 | 16.88 |
| 1080 | Other disorders of eye and adnexa | FING00001025 | 16.87 |
| 1081 | IDP dMRI TBSS ICVF External capsule L | GCST90004360 | 16.85 |
| 1082 | Clonal hematopoiesis (large clone) | GCST90102621 | 16.85 |
| 1083 | DTI TBSS L3 Posterior thalamic radiation R | GCST90384552 | 16.84 |
| 1084 | Alcohol dependence | FING00000050 | 16.83 |
| 1085 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T353 | ECGU000353 | 16.83 |
| 1086 | Diacylglycerol_36:5_[M+H-H2O]1+ levels | GCST90060187 | 16.78 |
| 1087 | Total lipids in very small VLDL | GCST90500810 | 16.75 |
| 1088 | Treatment or medication use - atorvastatin (UKB data field 20003_1141146234) | GCST90042376 | 16.74 |
| 1089 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T34 | ECGU000034 | 16.74 |
| 1090 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T122 | ECGU000122 | 16.73 |
| 1091 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T4 | ECGU000004 | 16.69 |
| 1092 | Trauma exposure | GCST009982 | 16.68 |
| 1093 | X-21441 levels | GCST90200581 | 16.68 |
| 1094 | IDP T1 FAST ROIs L cerebellum VIIb | GCST90002575 | 16.67 |
| 1095 | Gamma-glutamylglycine levels | GCST90199741 | 16.67 |
| 1096 | Total cholesterol minus HDL-C levels | GCST90499130 | 16.67 |
| 1097 | Disorders of synovium and tendon | FING00000462 | 16.66 |
| 1098 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502147 | 16.66 |
| 1099 | IDP dMRI ProbtrackX ISOVF fma | GCST90004535 | 16.64 |
| 1100 | Bell pepper liking | GCST90094703 | 16.63 |
| 1101 | Bell's palsy | FING00000144 | 16.63 |
| 1102 | Paracetamol of NSAID medication | FING00001145 | 16.62 |
| 1103 | DTI autoptx L2 ptr r tract | GCST90385186 | 16.60 |
| 1104 | Systolic blood pressure (weighted GWA) | GCST90267305 | 16.60 |
| 1105 | Volume of right whole amygdala | GCST90475054 | 16.59 |
| 1106 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T217 | ECGU000217 | 16.54 |
| 1107 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T125 | ECGU000125 | 16.53 |
| 1108 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502153 | 16.52 |
| 1109 | Triglycerides to total lipids ratio in very small VLDL | GCST90093039 | 16.52 |
| 1110 | Operative procedures - Palmar fasciectomy | Summary Operations | UKBB00000586 | 16.51 |
| 1111 | aparc-a2009s lh area S-calcarine | GCST90003340 | 16.50 |
| 1112 | MENT levels | GCST90469886 | 16.49 |
| 1113 | Cholesterol in IDL | GCST90497501 | 16.47 |
| 1114 | aparc-a2009s lh volume S-calcarine | GCST90002968 | 16.46 |
| 1115 | Vascular dementia (subcortical) | FING00001420 | 16.46 |
| 1116 | Spinal stenosis | musculoskeletal | UKBB00000792 | 16.45 |
| 1117 | Polyunsaturated fatty acid levels | GCST90502133 | 16.44 |
| 1118 | Cholesteryl Esters in IDL | GCST90497525 | 16.43 |
| 1119 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T265 | ECGA000265 | 16.43 |
| 1120 | Osteoarthritis, localized (PheCode 740.1) | GCST90476254 | 16.42 |
| 1121 | DTI autoptx L3 ptr l tract | GCST90385212 | 16.41 |
| 1122 | PRTG levels | GCST90470347 | 16.39 |
| 1123 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T105 | ECGU000105 | 16.38 |
| 1124 | IDP dMRI TBSS L1 External capsule L | GCST90004108 | 16.38 |
| 1125 | NSFL1C/PSMG3 ratio | GCST90315559 | 16.36 |
| 1126 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T205 | ECGA000205 | 16.34 |
| 1127 | Other cancer | GCST90475181 | 16.32 |
| 1128 | IDP dMRI TBSS MD Anterior limb of internal capsule R | GCST90004043 | 16.32 |
| 1129 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T229 | ECGA000229 | 16.30 |
| 1130 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T3 | ECGU000003 | 16.28 |
| 1131 | Duration to first press of snap-button in each round | Reaction time | UKBB00000202 | 16.28 |
| 1132 | Triglycerides to total lipids in medium VLDL percentage (UKB data field 23598) | GCST90269695 | 16.25 |
| 1133 | IDP dMRI TBSS ICVF Inferior cerebellar peduncle L | GCST90004338 | 16.25 |
| 1134 | Left ventricular end diastole inferoseptal wall thickness | GCST90278514 | 16.24 |
| 1135 | X-17676 levels | GCST90200548 | 16.22 |
| 1136 | Cholesterol to total lipids in medium VLDL percentage (UKB data field 23595) | GCST90269692 | 16.21 |
| 1137 | aparc-Desikan lh area pericalcarine | GCST90003093 | 16.19 |
| 1138 | IDP dMRI TBSS FA External capsule R | GCST90003909 | 16.18 |
| 1139 | Coffee type - Instant coffee | Diet | UKBB00000141 | 16.15 |
| 1140 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T118 | ECGA000118 | 16.14 |
| 1141 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502555 | 16.13 |
| 1142 | aparc-pial lh area lateraloccipital | GCST90003151 | 16.11 |
| 1143 | BA-exvivo lh volume BA2 | GCST90002836 | 16.11 |
| 1144 | Emphysema (PheCode 496.1) | GCST90476028 | 16.08 |
| 1145 | IDP dMRI ProbtrackX OD fmi | GCST90004461 | 16.07 |
| 1146 | DTI autoptx FA atr l tract | GCST90385114 | 16.03 |
| 1147 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T325 | ECGU000325 | 16.01 |
| 1148 | Insomnia (weighted GWA) | GCST90267287 | 15.97 |
| 1149 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T57 | ECGA000057 | 15.96 |
| 1150 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T166 | ECGA000166 | 15.96 |
| 1151 | PRSS8 levels | GCST90470345 | 15.96 |
| 1152 | KDR/VWF ratio | GCST90315245 | 15.95 |
| 1153 | IDP dMRI TBSS FA Posterior thalamic radiation R | GCST90003905 | 15.94 |
| 1154 | Cardiovascular delta age (difference between ECG-predicted and chronological age) | GCST90239749 | 15.93 |
| 1155 | aparc-Desikan rh thickness cuneus | GCST90003483 | 15.92 |
| 1156 | DTI autoptx L3 slf r tract | GCST90385215 | 15.91 |
| 1157 | Moderate to vigorous physical activity levels | GCST006097 | 15.88 |
| 1158 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T20 | ECGA000020 | 15.87 |
| 1159 | Body mass index | GCST90025994 | 15.86 |
| 1160 | Spatial QRS-T angle | GCST90246320 | 15.79 |
| 1161 | IDP dMRI ProbtrackX L2 ptr r | GCST90004293 | 15.78 |
| 1162 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T354 | ECGU000354 | 15.73 |
| 1163 | Testicular dysfunction (PheCode 257) | GCST90475696 | 15.72 |
| 1164 | Soft tissue disorders | FING00001316 | 15.72 |
| 1165 | Linoleic acid to total fatty acids percentage | GCST90502321 | 15.70 |
| 1166 | T1 CAT GM unnormalised volume | GCST90383982 | 15.70 |
| 1167 | Beef/steak liking | GCST90094700 | 15.70 |
| 1168 | aparc-DKTatlas rh thickness lateraloccipital | GCST90003580 | 15.69 |
| 1169 | IDP dMRI ProbtrackX MD fma | GCST90004229 | 15.69 |
| 1170 | Right-hemisphere somatomotor network to right-hemisphere default mode network white-matter structural connectivity | GCST90302793 | 15.67 |
| 1171 | Bone density (confirmatory factor analysis Factor 19) | GCST90309353 | 15.66 |
| 1172 | Other chronic obstructive pulmonary disease | Chronic lower respiratory diseases | UKBB00000604 | 15.63 |
| 1173 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T345 | ECGU000345 | 15.63 |
| 1174 | aparc-DKTatlas rh volume pericalcarine | GCST90002912 | 15.63 |
| 1175 | Cholesteryl esters to total lipids in very large VLDL percentage (UKB data field 23586) | GCST90269683 | 15.61 |
| 1176 | Concentration of large LDL particles | GCST90498029 | 15.59 |
| 1177 | DTI TBSS MD Retrolenticular part of internal capsule R | GCST90384592 | 15.57 |
| 1178 | Inguinal hernia | digestive | UKBB00000362 | 15.55 |
| 1179 | IDP dMRI TBSS L3 Anterior limb of internal capsule L | GCST90004188 | 15.55 |
| 1180 | Sleep apnea | GCST90475257 | 15.54 |
| 1181 | Omega-6 fatty acids to total fatty acids percentage | GCST90502529 | 15.53 |
| 1182 | Total fatty acid levels | GCST90502726 | 15.53 |
| 1183 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T67 | ECGA000067 | 15.52 |
| 1184 | T1 FreeSurfer BA lh BA4p exvivo thickness | GCST90385524 | 15.50 |
| 1185 | Volume of left anterior amygdaloid area | GCST90474934 | 15.48 |
| 1186 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T260 | ECGU000260 | 15.48 |
| 1187 | Spondylopathies | FING00001325 | 15.47 |
| 1188 | Monounsaturated fatty acid levels | GCST90502362 | 15.46 |
| 1189 | ThalamNuclei rh volume CM | GCST90002742 | 15.46 |
| 1190 | Torso length to body height ratio | GCST90270262 | 15.45 |
| 1191 | Omega-3 fatty acid levels | GCST90502055 | 15.44 |
| 1192 | aparc-pial lh area postcentral | GCST90003162 | 15.42 |
| 1193 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 128) | GCST90320947 | 15.42 |
| 1194 | Cheese intake | Diet | UKBB00000127 | 15.41 |
| 1195 | aparc-a2009s lh volume G+S-subcentral | GCST90002928 | 15.40 |
| 1196 | aparc-a2009s rh volume G-cingul-Post-ventral | GCST90003008 | 15.40 |
| 1197 | aparc-Desikan rh volume lingual | GCST90002813 | 15.39 |
| 1198 | Phospholipids to Total Lipids in IDL percentage | GCST90497644 | 15.36 |
| 1199 | Volume of left lateral nucleus | GCST90474970 | 15.36 |
| 1200 | Biological Father: High cholesterol | GCST90475242 | 15.35 |
| 1201 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T33 | ECGU000033 | 15.35 |
| 1202 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T71 | ECGA000071 | 15.34 |
| 1203 | Phospholipids to Total Lipids in Small LDL percentage | GCST90499690 | 15.32 |
| 1204 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T137 | ECGU000137 | 15.31 |
| 1205 | IDP dMRI TBSS L2 Superior cerebellar peduncle R | GCST90004135 | 15.30 |
| 1206 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502166 | 15.29 |
| 1207 | aparc-DKTatlas rh volume lingual | GCST90002904 | 15.29 |
| 1208 | aparc-a2009s rh area S-postcentral | GCST90003437 | 15.28 |
| 1209 | Phospholipids in LDL | GCST90498439 | 15.27 |
| 1210 | aparc-Desikan rh volume precentral | GCST90002824 | 15.27 |
| 1211 | Triglycerides to total lipids in very small VLDL percentage (UKB data field 23608) | GCST90269705 | 15.27 |
| 1212 | Alcohol frequency weekly (weighted GWA) | GCST90267267 | 15.27 |
| 1213 | Gastrointestinal issues (confirmatory factor analysis Factor 31) | GCST90309365 | 15.27 |
| 1214 | IDP T1 FAST ROIs L supracalc cortex | GCST90002543 | 15.24 |
| 1215 | aparc-Desikan lh volume lingual | GCST90002780 | 15.24 |
| 1216 | Total fatty acid levels | GCST90502711 | 15.23 |
| 1217 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T429 | ECGA000429 | 15.23 |
| 1218 | Other alveolar and parietoalveolar pneumonopathy (PheCode 504) | GCST90476033 | 15.22 |
| 1219 | aparc-Desikan lh area caudalmiddlefrontal | GCST90003076 | 15.20 |
| 1220 | Heart failure and coronary heart disease | FING00000604 | 15.19 |
| 1221 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T268 | ECGA000268 | 15.15 |
| 1222 | aparc-DKTatlas lh volume lingual | GCST90002873 | 15.13 |
| 1223 | Genital prolapse | genitourinary | UKBB00000282 | 15.13 |
| 1224 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T45 | ECGU000045 | 15.11 |
| 1225 | 3-hydroxydecanoate metabolite level | GCST90615472 | 15.11 |
| 1226 | Diastolic blood pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000177 | 15.11 |
| 1227 | ANGPTL2 levels | GCST90468303 | 15.10 |
| 1228 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T340 | ECGU000340 | 15.10 |
| 1229 | Cholesterol to total lipids in very large VLDL percentage (UKB data field 23585) | GCST90269682 | 15.09 |
| 1230 | Irritable bowel syndrome | GCST90016564 | 15.08 |
| 1231 | SCARA5/TNC ratio | GCST90315810 | 15.08 |
| 1232 | Average diameter for LDL particles | GCST90498457 | 15.08 |
| 1233 | Phospholipid levels in very small VLDL | GCST90132659 | 15.08 |
| 1234 | Treatment/medication code - omeprazole | Medications | UKBB00000852 | 15.05 |
| 1235 | Recurrent or chronic depression | FING00001243 | 15.03 |
| 1236 | Gastritis and duodenitis | digestive | UKBB00000277 | 15.02 |
| 1237 | Other aneurysm (PheCode 442) | GCST90475992 | 15.01 |
| 1238 | Heart valve disorders (PheCode 395) | GCST90475913 | 15.01 |
| 1239 | TNC/VCAM1 ratio | GCST90315927 | 15.00 |
| 1240 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T133 | ECGU000133 | 14.99 |
| 1241 | Vertiginous syndromes and other disorders of vestibular system (PheCode 386) | GCST90475905 | 14.98 |
| 1242 | T1 CAT volume R InsularCortex | GCST90384003 | 14.98 |
| 1243 | Types of physical activity in last 4 weeks - Strenuous sports | Physical activity | UKBB00000874 | 14.96 |
| 1244 | Autorefraction - 6mm strong meridian (right) | Eyesight | UKBB00000076 | 14.95 |
| 1245 | Total fatty acid levels | GCST90502211 | 14.92 |
| 1246 | Left ventricular end diastolic volume (indexed to body surface area) | GCST90435258 | 14.91 |
| 1247 | wg rh intensity-contrast inferiortemporal | GCST90003835 | 14.91 |
| 1248 | DTI autoptx FA atr r tract | GCST90385115 | 14.90 |
| 1249 | aparc-Desikan rh thickness lateraloccipital | GCST90003489 | 14.89 |
| 1250 | Episodal and paroxysmal disorders | FING00000514 | 14.87 |
| 1251 | Shortness of breath (PheCode 512.7) | GCST90476040 | 14.87 |
| 1252 | SPESP1 levels | GCST90470720 | 14.86 |
| 1253 | Middle diffusion tensor imaging along the perivascular space index | GCST90455544 | 14.84 |
| 1254 | CST3/IGFBP6 ratio | GCST90314293 | 14.78 |
| 1255 | SESTD1 levels | GCST90470604 | 14.77 |
| 1256 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T339 | ECGU000339 | 14.74 |
| 1257 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T363 | ECGU000363 | 14.74 |
| 1258 | T1 FreeSurfer DKT rh insula area | GCST90384317 | 14.69 |
| 1259 | Treatment or medication use - metformin (UKB data field 20003_1140884600) | GCST90042245 | 14.69 |
| 1260 | Job involves mainly walking or standing | Employment | UKBB00000384 | 14.68 |
| 1261 | Concentration of very small VLDL particles | GCST90500819 | 14.67 |
| 1262 | rfMRI connectivity ICA-features 2 | GCST90006340 | 14.67 |
| 1263 | Heel broadband ultrasound attenuation (right) | Bone-densitometry of heel | UKBB00000320 | 14.67 |
| 1264 | rfMRI amplitudes (ICA100 node 35) | GCST90004623 | 14.66 |
| 1265 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio (UKB data field 23458) | GCST90269555 | 14.65 |
| 1266 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T427 | ECGA000427 | 14.65 |
| 1267 | Overall health rating | General health | UKBB00000621 | 14.65 |
| 1268 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T56 | ECGU000056 | 14.62 |
| 1269 | Coxarthrosis, primary, with hip surgery | FING00000364 | 14.61 |
| 1270 | IDP dMRI TBSS ICVF Superior fronto-occipital fasciculus L | GCST90004370 | 14.61 |
| 1271 | MEPE levels | GCST90469889 | 14.61 |
| 1272 | Right ventricular ejection fraction | GCST90268117 | 14.58 |
| 1273 | Lumbar disc prolapse | FING00000735 | 14.52 |
| 1274 | IDP T1 FAST ROIs L planum temporale | GCST90002541 | 14.51 |
| 1275 | Sphingomyelin_38:1_[M+H]1+ levels | GCST90060306 | 14.51 |
| 1276 | Skin color (cheek, B value) | GCST90502779 | 14.51 |
| 1277 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T426 | ECGA000426 | 14.47 |
| 1278 | Biological Father: High blood pressure | GCST90475243 | 14.46 |
| 1279 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T308 | ECGU000308 | 14.44 |
| 1280 | Left ventricular end systole anterolateral wall thickness | GCST90278511 | 14.41 |
| 1281 | DTI autoptx L3 ifo r tract | GCST90385206 | 14.41 |
| 1282 | Myopia (PheCode 367.1) | GCST90475880 | 14.37 |
| 1283 | CDKN1A/TXLNA ratio | GCST90313979 | 14.34 |
| 1284 | Cardiomyopathy (PheCode 425) | GCST90475949 | 14.33 |
| 1285 | Physical activity (Total log acceleration 12am-2am) | GCST90061409 | 14.31 |
| 1286 | Primary/intrinsic cardiomyopathies (PheCode 425.1) | GCST90475951 | 14.31 |
| 1287 | Number of fluid intelligence questions attempted within time limit | Fluid intelligence / reasoning | UKBB00000537 | 14.30 |
| 1288 | Cereal type - Muesli | Diet | UKBB00000123 | 14.30 |
| 1289 | Total Lipids in LDL | GCST90498405 | 14.29 |
| 1290 | 1-stearoyl-2-arachidonoyl-GPI (18:0/20:4) levels | GCST90199649 | 14.29 |
| 1291 | Total lipids in large LDL | GCST90498021 | 14.28 |
| 1292 | Cholesteryl ester_18:0_[M+NH4]1+ levels | GCST90060222 | 14.28 |
| 1293 | IDP dMRI TBSS L1 Splenium of corpus callosum | GCST90004079 | 14.23 |
| 1294 | IDP dMRI TBSS L2 External capsule R | GCST90004155 | 14.23 |
| 1295 | Sleep duration | GCST003839 | 14.21 |
| 1296 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T226 | ECGA000226 | 14.21 |
| 1297 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T425 | ECGA000425 | 14.20 |
| 1298 | aparc-a2009s rh volume S-central | GCST90003043 | 14.20 |
| 1299 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T86 | ECGA000086 | 14.20 |
| 1300 | Phosphatidylinositol-O_36:0_[M-H]1- levels | GCST90060480 | 14.18 |
| 1301 | Poultry consumption | GCST90132996 | 14.18 |
| 1302 | DTI TBSS L2 Uncinate fasciculus R | GCST90384520 | 14.18 |
| 1303 | Anemia of chronic disease (PheCode 285.2) | GCST90475790 | 14.18 |
| 1304 | Secondary hypothyroidism (PheCode 244.1) | GCST90475649 | 14.17 |
| 1305 | LDL cholesterol levels | GCST90498353 | 14.15 |
| 1306 | IDP dMRI TBSS L3 Superior corona radiata L | GCST90004196 | 14.13 |
| 1307 | Total free cholesterol levels | GCST90500072 | 14.13 |
| 1308 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T265 | ECGU000265 | 14.13 |
| 1309 | Principal component-derived dietary pattern 4 | GCST90133009 | 14.12 |
| 1310 | Other peripheral nerve disorders (PheCode 351) | GCST90475842 | 14.07 |
| 1311 | Obstructive chronic bronchitis | respiratory | UKBB00000546 | 14.06 |
| 1312 | aparc-Desikan rh volume pericalcarine | GCST90002821 | 14.06 |
| 1313 | Tinnitus | GCST90448242 | 14.04 |
| 1314 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 86) | GCST90320905 | 14.04 |
| 1315 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T60 | ECGU000060 | 14.04 |
| 1316 | Hemoglobin A1c (HbA1c, maximum, inv-norm transformed) | GCST90475091 | 14.03 |
| 1317 | Ever felt worried, tense, or anxious for most of a month or longer | Anxiety | UKBB00000215 | 14.01 |
| 1318 | Diseases of esophagus (PheCode 530) | GCST90476045 | 13.99 |
| 1319 | ISEI occupational score | GCST90446160 | 13.96 |
| 1320 | aparc-DKTatlas lh area caudalmiddlefrontal | GCST90003236 | 13.96 |
| 1321 | aparc-DKTatlas lh area cuneus | GCST90003237 | 13.95 |
| 1322 | DTI TBSS L3 Retrolenticular part of internal capsule R | GCST90384544 | 13.94 |
| 1323 | Total lipids in IDL | GCST90497601 | 13.94 |
| 1324 | Cholesteryl esters to total lipids in medium VLDL percentage (UKB data field 23596) | GCST90269693 | 13.94 |
| 1325 | IDP dMRI TBSS MD Splenium of corpus callosum | GCST90004031 | 13.94 |
| 1326 | IDP dMRI TBSS L1 Inferior cerebellar peduncle L | GCST90004086 | 13.93 |
| 1327 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T367 | ECGU000367 | 13.93 |
| 1328 | Peripheral vascular disease | GCST90475219 | 13.92 |
| 1329 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502645 | 13.92 |
| 1330 | Age started wearing glasses or contact lenses | Eyesight | UKBB00000017 | 13.92 |
| 1331 | Phospholipids to Total Lipids in Very Small VLDL percentage | GCST90500856 | 13.91 |
| 1332 | aparc-DKTatlas rh area postcentral | GCST90003285 | 13.90 |
| 1333 | IDP dMRI ProbtrackX L1 ifo l | GCST90004258 | 13.89 |
| 1334 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T346 | ECGU000346 | 13.89 |
| 1335 | IDP dMRI ProbtrackX ISOVF ifo r | GCST90004538 | 13.86 |
| 1336 | Diastolic blood pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000176 | 13.85 |
| 1337 | Mean diameter of VLDL particles | GCST90132734 | 13.85 |
| 1338 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T430 | ECGA000430 | 13.85 |
| 1339 | Staphylococcus A fleurettii abundance in stool | GCST90032564 | 13.83 |
| 1340 | Forced vital capacity FVC Z score (UKB data field 20257) | GCST90468167 | 13.82 |
| 1341 | Pain type(s) experienced in last month - None of the above | Pain | UKBB00000631 | 13.82 |
| 1342 | Phospholipids to total lipids in chylomicrons and extremely large VLDL percentage (UKB data field 23579) | GCST90269676 | 13.81 |
| 1343 | Mean time to correctly identify matches | Reaction time | UKBB00000453 | 13.80 |
| 1344 | JAM2 levels | GCST90469659 | 13.80 |
| 1345 | DTI autoptx FA unc l tract | GCST90385137 | 13.80 |
| 1346 | aseg rh volume choroid-plexus | GCST90002646 | 13.79 |
| 1347 | Age at first birth | GCST90000048 | 13.77 |
| 1348 | Omega-6 fatty acids to total fatty acids percentage | GCST90502121 | 13.76 |
| 1349 | DTI TBSS L2 Superior longitudinal fasciculus R | GCST90384516 | 13.76 |
| 1350 | Total triglycerides levels | GCST003664 | 13.73 |
| 1351 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 26) | GCST90320589 | 13.73 |
| 1352 | Linoleic acid to total fatty acids percentage | GCST90502017 | 13.73 |
| 1353 | BA-exvivo rh area perirhinal | GCST90003233 | 13.73 |
| 1354 | IDP dMRI TBSS MO Pontine crossing tract | GCST90003953 | 13.72 |
| 1355 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T206 | ECGU000206 | 13.71 |
| 1356 | CD84/TREML2 ratio | GCST90313919 | 13.70 |
| 1357 | BAIAP2/MME ratio | GCST90313453 | 13.70 |
| 1358 | BA-exvivo lh volume BA3a | GCST90002837 | 13.69 |
| 1359 | IDP dMRI TBSS ISOVF External capsule L | GCST90004510 | 13.68 |
| 1360 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T117 | ECGA000117 | 13.67 |
| 1361 | Non-mucinous epithelial ovarian cancer | GCST90244167 | 13.64 |
| 1362 | Heart rate variability traits (SDNN) | GCST004734 | 13.62 |
| 1363 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T167 | ECGA000167 | 13.61 |
| 1364 | CALCOCO1/TJAP1 ratio | GCST90313611 | 13.61 |
| 1365 | Primary Raynaud’s phenomenon | GCST90271714 | 13.61 |
| 1366 | APOB levels | GCST90497130 | 13.58 |
| 1367 | Other noninflammatory disorders of uterus, except cervix | FING00001079 | 13.58 |
| 1368 | Erythronate levels | GCST90243696 | 13.58 |
| 1369 | Intelligence | GCST004364 | 13.58 |
| 1370 | Triglyceride levels in very small VLDL | GCST90132669 | 13.57 |
| 1371 | Severe, life-threatening illness (confirmatory factor analysis Factor 20) | GCST90309354 | 13.56 |
| 1372 | Treatment/medication code - lisinopril | Medications | UKBB00000850 | 13.55 |
| 1373 | IDP dMRI ProbtrackX MD cst r | GCST90004228 | 13.53 |
| 1374 | IDP dMRI ProbtrackX L1 unc r | GCST90004272 | 13.52 |
| 1375 | Hippocampal left GC-ML-DG volume (head) | GCST90267946 | 13.52 |
| 1376 | Phosphatidylcholine (18:0_20:3) levels | GCST90024876 | 13.51 |
| 1377 | IDP dMRI ProbtrackX MD ar r | GCST90004220 | 13.50 |
| 1378 | Lysoalkylphosphatidylcholine (O-22:1) levels | GCST90024196 | 13.49 |
| 1379 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T431 | ECGA000431 | 13.49 |
| 1380 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 119) | GCST90320938 | 13.48 |
| 1381 | IDP dMRI TBSS L3 External capsule R | GCST90004203 | 13.47 |
| 1382 | T1 FreeSurfer DKT rh supramarginal volume | GCST90384377 | 13.46 |
| 1383 | Acquired absence of organs, not elsewhere classified | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000005 | 13.45 |
| 1384 | EGFLAM levels | GCST90421651 | 13.44 |
| 1385 | CFH levels | GCST90468729 | 13.44 |
| 1386 | IDP dMRI ProbtrackX L3 unc r | GCST90004326 | 13.44 |
| 1387 | Weekly usage of mobile phone in last 3 months | Electronic device use | UKBB00000908 | 13.41 |
| 1388 | IDP dMRI ProbtrackX FA cst l | GCST90003933 | 13.41 |
| 1389 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T309 | ECGA000309 | 13.41 |
| 1390 | heart rate (HR, minimum, inv-normal transformed) | GCST90476341 | 13.40 |
| 1391 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T264 | ECGA000264 | 13.39 |
| 1392 | Asphyxia and hypoxemia (PheCode 1013) | GCST90475559 | 13.39 |
| 1393 | IDP dMRI ProbtrackX FA ptr r | GCST90003945 | 13.37 |
| 1394 | Frequency of travelling from home to job workplace | Employment | UKBB00000269 | 13.36 |
| 1395 | IDP dMRI TBSS L3 Superior cerebellar peduncle R | GCST90004183 | 13.35 |
| 1396 | PBLD levels | GCST90470163 | 13.34 |
| 1397 | Mineral and other dietary supplements - Zinc | Medication | UKBB00000476 | 13.33 |
| 1398 | Liver volume (adjusted for height) | GCST90566819 | 13.31 |
| 1399 | aparc-DKTatlas lh volume pericalcarine | GCST90002881 | 13.31 |
| 1400 | Other intervertebral disc disorders | FING00001063 | 13.31 |
| 1401 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T269 | ECGA000269 | 13.30 |
| 1402 | BMI and adiposity (confirmatory factor analysis Factor 7) | GCST90309342 | 13.30 |
| 1403 | PYY levels | GCST90470398 | 13.28 |
| 1404 | IDP dMRI TBSS L2 Superior corona radiata R | GCST90004147 | 13.28 |
| 1405 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T125 | ECGA000125 | 13.28 |
| 1406 | IDP dMRI ProbtrackX L2 ar l | GCST90004273 | 13.27 |
| 1407 | Atrial fibrillation and flutter with reimbursement | FING00000127 | 13.27 |
| 1408 | IDP dMRI ProbtrackX L2 cgc l | GCST90004277 | 13.26 |
| 1409 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T43 | ECGU000043 | 13.25 |
| 1410 | Cholesteryl Esters in LDL | GCST90498363 | 13.25 |
| 1411 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T344 | ECGU000344 | 13.25 |
| 1412 | aparc-pial lh area cuneus | GCST90003145 | 13.24 |
| 1413 | DTI TBSS L2 Sagittal stratum L | GCST90384507 | 13.23 |
| 1414 | IDP dMRI ProbtrackX L3 ptr r | GCST90004320 | 13.21 |
| 1415 | IDP dMRI ProbtrackX ICVF str r | GCST90004399 | 13.18 |
| 1416 | Comfortable retirement (confirmatory factor analysis Factor 29) | GCST90309363 | 13.18 |
| 1417 | EFNA4/LAYN ratio | GCST90314602 | 13.14 |
| 1418 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T121 | ECGA000121 | 13.14 |
| 1419 | Ratio of linoleic acid to total fatty acids | GCST90092881 | 13.13 |
| 1420 | Frailty (Factor 5 - Poorer Cognition) | GCST90624051 | 13.13 |
| 1421 | Hip circumference (UKB data field 49) | GCST90468170 | 13.12 |
| 1422 | Pulse pressure, automated reading | Cardiovascular measurement | UKBB00000714 | 13.10 |
| 1423 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T120 | ECGU000120 | 13.09 |
| 1424 | Clinical LDL cholesterol levels | GCST90497223 | 13.08 |
| 1425 | COL1A1 levels | GCST90240744 | 13.08 |
| 1426 | aparc-a2009s rh volume G-pariet-inf-Supramar | GCST90003024 | 13.07 |
| 1427 | CD20 on IgD- CD38- B cell | GCST90001755 | 13.06 |
| 1428 | Pulse pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000716 | 13.06 |
| 1429 | ENO2/SCRN1 ratio | GCST90314668 | 13.05 |
| 1430 | Diabetes mellitus (PheCode 250) | GCST90475658 | 13.05 |
| 1431 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T115 | ECGU000115 | 13.00 |
| 1432 | Concentration of LDL particles | GCST90498418 | 12.98 |
| 1433 | Main speciality of consultant (recoded) - General medicine | Summary Administration | UKBB00000416 | 12.97 |
| 1434 | Operative procedures - Closed reduction of fracture of bone and fixation using nail or screw | Summary Operations | UKBB00000575 | 12.96 |
| 1435 | Cholesterol in Small VLDL | GCST90499750 | 12.96 |
| 1436 | Hip circumference adjusted for BMI | GCST90020028 | 12.95 |
| 1437 | IDP dMRI TBSS FA Anterior corona radiata R | GCST90003899 | 12.92 |
| 1438 | Occupational attainment | GCST90102253 | 12.91 |
| 1439 | DTI TBSS MD Sagittal stratum L | GCST90384603 | 12.91 |
| 1440 | Cholesteryl Esters to Total Lipids in Large LDL percentage | GCST90497969 | 12.90 |
| 1441 | RGMB/THY1 ratio | GCST90315771 | 12.89 |
| 1442 | Monounsaturated fatty acid levels | GCST90502038 | 12.89 |
| 1443 | IDP T1 FAST ROIs V cerebellum VIIIa | GCST90002579 | 12.88 |
| 1444 | CASP3/LYN ratio | GCST90313635 | 12.87 |
| 1445 | REST UKBBICA NODEamps25 0009 | GCST90385492 | 12.86 |
| 1446 | Familial combined hyperlipidemia defined by Mexico criteria | GCST90104007 | 12.85 |
| 1447 | COMP/THBS4 ratio | GCST90314193 | 12.84 |
| 1448 | Diastolic blood pressure, automated reading | Blood pressure | UKBB00000173 | 12.81 |
| 1449 | APP/NID2 ratio | GCST90313327 | 12.78 |
| 1450 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T202 | ECGA000202 | 12.77 |
| 1451 | Volume of right cortical nucleus | GCST90475030 | 12.77 |
| 1452 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T113 | ECGU000113 | 12.76 |
| 1453 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T116 | ECGA000116 | 12.75 |
| 1454 | Congenital malformations of genital organs | FING00000333 | 12.74 |
| 1455 | Left-hemisphere default mode network to right-hemisphere somatomotor network white-matter structural connectivity | GCST90302761 | 12.72 |
| 1456 | Tea intake (UKB data field 1488) | GCST90132983 | 12.70 |
| 1457 | Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS), excluding all cancers (controls excluding all cancers) | FING00000846 | 12.69 |
| 1458 | Physical activity (Total log acceleration 2am-4am) | GCST90061410 | 12.68 |
| 1459 | Coffee type - Decaffeinated coffee (any type) | Diet | UKBB00000139 | 12.68 |
| 1460 | Heel quantitative ultrasound index (QUI), direct entry | Bone-densitometry of heel | UKBB00000324 | 12.67 |
| 1461 | Heel bone mineral density (BMD) T-score, automated | Bone-densitometry of heel | UKBB00000318 | 12.67 |
| 1462 | Principal component-derived dietary pattern 24 | GCST90133029 | 12.67 |
| 1463 | Triglycerides to total lipids in small VLDL percentage (UKB data field 23603) | GCST90269700 | 12.67 |
| 1464 | aparc-Desikan lh volume pericalcarine | GCST90002788 | 12.66 |
| 1465 | DTI TBSS L3 Retrolenticular part of internal capsule L | GCST90384545 | 12.64 |
| 1466 | Back pain (PheCode 760) | GCST90476266 | 12.63 |
| 1467 | Other cataract | FING00000976 | 12.63 |
| 1468 | T1 FIRST volume BrStem | GCST90383989 | 12.63 |
| 1469 | Cholesterol to Total Lipids in Medium VLDL percentage | GCST90498926 | 12.62 |
| 1470 | Cardiomyopathy | GCST90399705 | 12.62 |
| 1471 | IDP dMRI TBSS OD External capsule L | GCST90004435 | 12.61 |
| 1472 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T2 | ECGU000002 | 12.59 |
| 1473 | Total cholesterol levels in medium VLDL | GCST90132689 | 12.59 |
| 1474 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T65 | ECGU000065 | 12.59 |
| 1475 | Cholesterol to Total Lipids in IDL percentage | GCST90497511 | 12.58 |
| 1476 | IDP dMRI TBSS ICVF Fornix | GCST90004332 | 12.57 |
| 1477 | T2 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 78) | GCST90320897 | 12.55 |
| 1478 | Pulse pressure, automated reading | Cardiovascular measurement | UKBB00000715 | 12.54 |
| 1479 | ADAMTS8/FAP ratio | GCST90313172 | 12.53 |
| 1480 | Lysoalkylphosphatidylcholine (O-24:1) levels | GCST90024198 | 12.53 |
| 1481 | Type 2 diabetes (PheCode 250.2) | GCST90475667 | 12.52 |
| 1482 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T445 | ECGA000445 | 12.52 |
| 1483 | Cholesterol to total lipids ratio in medium LDL | GCST90092905 | 12.52 |
| 1484 | Treatment speciality of consultant (recoded) - General medicine | Summary Administration | UKBB00000832 | 12.51 |
| 1485 | DTI autoptx L2 ilf r tract | GCST90385181 | 12.51 |
| 1486 | aparc-Desikan rh volume lateraloccipital | GCST90002811 | 12.51 |
| 1487 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T172 | ECGA000172 | 12.51 |
| 1488 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T153 | ECGU000153 | 12.50 |
| 1489 | IDP SWI T2star right thalamus | GCST90003864 | 12.49 |
| 1490 | 1-(1-enyl-palmitoyl)-GPC (p-16:0) levels | GCST90199899 | 12.49 |
| 1491 | aparc-a2009s rh area Pole-occipital | GCST90003412 | 12.47 |
| 1492 | Total lipids in small LDL | GCST90499656 | 12.47 |
| 1493 | Chronic rhinitis, nasopharyngitis and pharyngitis | FING00000297 | 12.46 |
| 1494 | Delta body mass index (difference between ECG-predicted and measured) | GCST90429062 | 12.45 |
| 1495 | IDP dMRI ProbtrackX MD unc r | GCST90004245 | 12.44 |
| 1496 | Monounsaturated fatty acids to total fatty acids percentage (UKB data field 23454) | GCST90269551 | 12.41 |
| 1497 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 58) | GCST90320621 | 12.41 |
| 1498 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T317 | ECGA000317 | 12.40 |
| 1499 | AIFM1/SIRT2 ratio | GCST90313221 | 12.40 |
| 1500 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T298 | ECGU000298 | 12.39 |
| 1501 | Omega-6 fatty acids to total fatty acids percentage | GCST90502127 | 12.39 |
| 1502 | Sphingomyelin_42:2_[M+OAc]1- levels | GCST90060507 | 12.39 |
| 1503 | Acid reflux/GERD | GCST90475320 | 12.39 |
| 1504 | Cholesteryl Esters to Total Lipids in Medium VLDL percentage | GCST90498944 | 12.38 |
| 1505 | ICA1/TANK ratio | GCST90315112 | 12.38 |
| 1506 | Left-hemisphere limbic network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302732 | 12.37 |
| 1507 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T123 | ECGU000123 | 12.37 |
| 1508 | Heel bone mineral density (BMD) | Bone-densitometry of heel | UKBB00000315 | 12.37 |
| 1509 | Non-small cell lung cancer, squamous, excluding all cancers (controls excluding all cancers) | FING00000877 | 12.36 |
| 1510 | Benign neoplasm of colon | neoplasms | UKBB00000092 | 12.34 |
| 1511 | Right-hemisphere visual network to pallidum white-matter structural connectivity | GCST90302784 | 12.34 |
| 1512 | Triacylglycerol (48:2) [NL-16:0] levels | GCST90025143 | 12.34 |
| 1513 | Free Cholesterol to Total Lipids in Very Small VLDL percentage | GCST90500798 | 12.33 |
| 1514 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T238 | ECGA000238 | 12.33 |
| 1515 | Systolic blood pressure (UKB data field 4080) | GCST90468179 | 12.33 |
| 1516 | IDP dMRI TBSS L2 Cingulum hippocampus R | GCST90004159 | 12.32 |
| 1517 | Autorefraction - 3mm strong meridian angle (right) | Eyesight | UKBB00000068 | 12.32 |
| 1518 | Plasma cystathionine levels in chronic kidney disease | GCST90264974 | 12.32 |
| 1519 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T286 | ECGA000286 | 12.31 |
| 1520 | Nontoxic goitre/thyroid nodule | FING00000887 | 12.31 |
| 1521 | Number of sexual partners in opposite-sex sexual behavior | GCST90026482 | 12.30 |
| 1522 | X-14626 levels | GCST90243861 | 12.30 |
| 1523 | Reaction time | GCST006268 | 12.30 |
| 1524 | Free cholesterol to total lipids in medium VLDL percentage (UKB data field 23597) | GCST90269694 | 12.29 |
| 1525 | Pulse pressure, automated reading, adjusted by medication | Cardiovascular measurement | UKBB00000717 | 12.29 |
| 1526 | Fibromuscular dysplasia | GCST90026612 | 12.29 |
| 1527 | Arthropathy NOS | musculoskeletal | UKBB00000051 | 12.29 |
| 1528 | IGFBPL1 levels | GCST90469533 | 12.29 |
| 1529 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T211 | ECGU000211 | 12.28 |
| 1530 | Type 2 diabetes with ophthalmic manifestations (PheCode 250.23) | GCST90475673 | 12.28 |
| 1531 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T239 | ECGA000239 | 12.27 |
| 1532 | IDP T1 FAST ROIs L cerebellum I-IV | GCST90002562 | 12.24 |
| 1533 | aparc-a2009s lh area G-parietal-sup | GCST90003323 | 12.24 |
| 1534 | Principal component-derived dietary pattern 1 | GCST90133006 | 12.23 |
| 1535 | DTI autoptx L3 str l tract | GCST90385216 | 12.23 |
| 1536 | Triglycerides in large LDL | GCST90498083 | 12.22 |
| 1537 | IDP dMRI TBSS ICVF Superior cerebellar peduncle L | GCST90004340 | 12.21 |
| 1538 | ITGB1BP2/PTPN6 ratio | GCST90315218 | 12.21 |
| 1539 | Triacylglycerol_45:4_[M+NH4]1+ levels | GCST90060333 | 12.21 |
| 1540 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 124) | GCST90320687 | 12.19 |
| 1541 | IDP dMRI TBSS L2 Posterior corona radiata L | GCST90004150 | 12.19 |
| 1542 | Fibroblastic disorders | Other soft tissue disorders | UKBB00000246 | 12.18 |
| 1543 | NCAN levels | GCST90618559 | 12.18 |
| 1544 | Alcohol consumption | GCST90133003 | 12.18 |
| 1545 | Pulse pressure | GCST90301701 | 12.18 |
| 1546 | Cholesterol to Total Lipids in Very Small VLDL percentage | GCST90500731 | 12.17 |
| 1547 | Pain and other conditions associated with female genital organs and menstrual cycle | FING00001136 | 12.17 |
| 1548 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T333 | ECGU000333 | 12.16 |
| 1549 | Pulse pressure | GCST90301703 | 12.16 |
| 1550 | Phospholipids to Total Lipids in Large LDL percentage | GCST90498058 | 12.15 |
| 1551 | Metabolic syndrome | GCST90444489 | 12.15 |
| 1552 | Water consumption (glasses per day) (UKB data field 1528) | GCST90132985 | 12.15 |
| 1553 | Qualifications - Other professional qualifications eg: nursing, teaching | Education | UKBB00000732 | 12.13 |
| 1554 | Early age-related macular degeneration | GCST010723 | 12.12 |
| 1555 | aparc-DKTatlas lh thickness cuneus | GCST90003543 | 12.12 |
| 1556 | Chronic bronchitis | respiratory | UKBB00000136 | 12.09 |
| 1557 | IDP T1 FIRST left hippocampus volume | GCST90002444 | 12.08 |
| 1558 | BA-exvivo rh area entorhinal | GCST90003234 | 12.08 |
| 1559 | Free cholesterol in small VLDL | GCST90499817 | 12.06 |
| 1560 | Triglycerides to total lipids ratio in small VLDL | GCST90092979 | 12.05 |
| 1561 | Triglycerides in IDL | GCST90497661 | 12.04 |
| 1562 | Hyperplasia of prostate | FING00000635 | 12.03 |
| 1563 | IDP dMRI TBSS L2 Sagittal stratum L | GCST90004154 | 12.03 |
| 1564 | Medication for pain relief, constipation, heartburn - Omeprazole (e.g. Zanprol) | Medication | UKBB00000458 | 12.02 |
| 1565 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 121) | GCST90320684 | 12.02 |
| 1566 | IDP dMRI ProbtrackX L3 ifo l | GCST90004312 | 12.01 |
| 1567 | PMVK/PRTFDC1 ratio | GCST90315695 | 11.99 |
| 1568 | IDP dMRI ProbtrackX L2 atr l | GCST90004275 | 11.99 |
| 1569 | Fracture of forearm | GCST90281273 | 11.99 |
| 1570 | DTI TBSS L3 Sagittal stratum L | GCST90384555 | 11.98 |
| 1571 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T72 | ECGA000072 | 11.97 |
| 1572 | Parkinson's disease | FING00001150 | 11.96 |
| 1573 | Pelvic inlet width | GCST90448910 | 11.95 |
| 1574 | IDP dMRI ProbtrackX L3 cgc l | GCST90004304 | 11.95 |
| 1575 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T316 | ECGA000316 | 11.93 |
| 1576 | Retinal vascular disorders | FING00001262 | 11.93 |
| 1577 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T449 | ECGA000449 | 11.92 |
| 1578 | INSR levels | GCST90241509 | 11.92 |
| 1579 | CHRDL1/SMOC2 ratio | GCST90314062 | 11.91 |
| 1580 | aseg global volume-ratio BrainSegVol-to-eTIV | GCST90002612 | 11.89 |
| 1581 | Age when finished full-time education (standard GWA) | GCST90267280 | 11.89 |
| 1582 | DHX58 levels | GCST90618238 | 11.89 |
| 1583 | Fracture at wrist and hand level | FING00000551 | 11.89 |
| 1584 | Sphingomyelin (d17:1/16:0, d18:1/15:0, d16:1/17:0) levels | GCST90200017 | 11.88 |
| 1585 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T447 | ECGA000447 | 11.88 |
| 1586 | Thoracic aortic aneurysm | FING00001357 | 11.85 |
| 1587 | IDP dMRI ProbtrackX FA slf r | GCST90003947 | 11.83 |
| 1588 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T35 | ECGU000035 | 11.83 |
| 1589 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T51 | ECGU000051 | 11.82 |
| 1590 | IDP dMRI TBSS OD Pontine crossing tract | GCST90004403 | 11.80 |
| 1591 | Other arthropathies | musculoskeletal | UKBB00000601 | 11.78 |
| 1592 | Takes medication for enlarged prostate (Benign prostatic hyperplasia)? | GCST90475262 | 11.78 |
| 1593 | Osteoarthritis | GCST90134279 | 11.76 |
| 1594 | IDP dMRI ProbtrackX ICVF ml l | GCST90004392 | 11.75 |
| 1595 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T57 | ECGU000057 | 11.74 |
| 1596 | Linoleic acid levels | GCST90498306 | 11.73 |
| 1597 | Maximum indexed left atrial volume | GCST90019012 | 11.71 |
| 1598 | Hemoglobin concentration variance | GCST90565685 | 11.71 |
| 1599 | Body mass index | GCST90446645 | 11.71 |
| 1600 | SSH3 levels | GCST90470749 | 11.70 |
| 1601 | LDL cholesterol | GCST000759 | 11.70 |
| 1602 | Saturated fatty acids levels | GCST90502185 | 11.70 |
| 1603 | DTI TBSS MD Superior fronto-occipital fasciculus L | GCST90384615 | 11.69 |
| 1604 | Triglycerides in small VLDL | GCST90499915 | 11.68 |
| 1605 | aparc-DKTatlas rh volume precentral | GCST90002915 | 11.68 |
| 1606 | Hemoglobin A1c (HbA1c, mean, inv-norm transformed) | GCST90475094 | 11.68 |
| 1607 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T450 | ECGA000450 | 11.67 |
| 1608 | T1 FreeSurfer DKT rh lateraloccipital volume | GCST90384357 | 11.66 |
| 1609 | Total phospholipid levels in lipoprotein particles | GCST90500110 | 11.66 |
| 1610 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T282 | ECGA000282 | 11.65 |
| 1611 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T366 | ECGU000366 | 11.65 |
| 1612 | PADI4 levels | GCST90470143 | 11.65 |
| 1613 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T266 | ECGU000266 | 11.64 |
| 1614 | ICD10 O60: Preterm labor and delivery | GCST90454242 | 11.64 |
| 1615 | DTI TBSS L2 Retrolenticular part of internal capsule R | GCST90384496 | 11.63 |
| 1616 | IDP dMRI TBSS L3 Uncinate fasciculus L | GCST90004216 | 11.62 |
| 1617 | Cholesteryl Esters to Total Lipids in IDL percentage | GCST90497539 | 11.61 |
| 1618 | VNN2 levels | GCST90618510 | 11.61 |
| 1619 | FAM3D levels | GCST90469188 | 11.60 |
| 1620 | Barrett's esophagus or Esophageal adenocarcinoma | GCST003740 | 11.60 |
| 1621 | Phospholipids in small VLDL | GCST90499871 | 11.60 |
| 1622 | aparc-Desikan rh area postcentral | GCST90003128 | 11.59 |
| 1623 | Cholesterol to Total Lipids in Small LDL percentage | GCST90499564 | 11.59 |
| 1624 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T152 | ECGU000152 | 11.59 |
| 1625 | IGFBP2 levels | GCST90469528 | 11.58 |
| 1626 | IDP dMRI TBSS MO Posterior corona radiata R | GCST90003978 | 11.57 |
| 1627 | ThalamNuclei lh volume MDl | GCST90002724 | 11.57 |
| 1628 | IDP dMRI TBSS L2 Anterior corona radiata R | GCST90004145 | 11.56 |
| 1629 | DTI autoptx L2 str l tract | GCST90385189 | 11.53 |
| 1630 | IDP dMRI TBSS FA Posterior thalamic radiation L | GCST90003906 | 11.53 |
| 1631 | DTI TBSS MD External capsule L | GCST90384605 | 11.52 |
| 1632 | Body fat percentage (adjusted for testosterone and SHBG) | GCST90432179 | 11.50 |
| 1633 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T5 | ECGU000005 | 11.50 |
| 1634 | Body mass index | GCST004904 | 11.48 |
| 1635 | IDP dMRI TBSS L2 Cingulum cingulate gyrus R | GCST90004157 | 11.48 |
| 1636 | FAS levels | GCST90090701 | 11.47 |
| 1637 | NPHS2 levels | GCST90470071 | 11.47 |
| 1638 | Inguinal hernia (PheCode 550.1) | GCST90476060 | 11.47 |
| 1639 | Glycine levels | GCST90200707 | 11.46 |
| 1640 | IDP dMRI ProbtrackX ICVF ar l | GCST90004375 | 11.44 |
| 1641 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T312 | ECGA000312 | 11.44 |
| 1642 | Ratio of monounsaturated fatty acids to total fatty acids | GCST90092929 | 11.42 |
| 1643 | Cholesterol in Large VLDL | GCST90498123 | 11.42 |
| 1644 | FLRT2/GFRA3 ratio | GCST90314855 | 11.42 |
| 1645 | Mean volume of bilateral amygdala | GCST90474901 | 11.42 |
| 1646 | Takes medication for Chronic lung diseases including COPD, Emphysema and Bronchitis? | GCST90475273 | 11.41 |
| 1647 | Free cholesterol in very small VLDL | GCST90500777 | 11.40 |
| 1648 | Cholesterol levels in very large VLDL | GCST90500517 | 11.40 |
| 1649 | Gastritis and duodenitis | Diseases of oesophagus, stomach and duodenum | UKBB00000278 | 11.39 |
| 1650 | DTI TBSS FA External capsule L | GCST90384413 | 11.39 |
| 1651 | ZNF830 levels | GCST90471102 | 11.38 |
| 1652 | Free cholesterol to total lipids ratio in chylomicrons and extremely large VLDL | GCST90093045 | 11.38 |
| 1653 | Peripheral vascular disease | GCST90475996 | 11.37 |
| 1654 | Hearing difficulty and hearing difficulty with background noise | GCST90245768 | 11.37 |
| 1655 | Aniseed liking | GCST90094689 | 11.37 |
| 1656 | T1 FreeSurfer DK rh supramarginal volume | GCST90385787 | 11.31 |
| 1657 | Infantile hypertrophic pyloric stenosis | GCST006705 | 11.31 |
| 1658 | MCAM/NCAM1 ratio | GCST90315408 | 11.31 |
| 1659 | Whole body fat mass (UKB data field 23100) | GCST90428121 | 11.31 |
| 1660 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T201 | ECGU000201 | 11.30 |
| 1661 | Volume of right cortical nucleus | GCST90475033 | 11.28 |
| 1662 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502554 | 11.27 |
| 1663 | DTI TBSS L1 Body of corpus callosum | GCST90384431 | 11.27 |
| 1664 | Polyunsaturated fatty acids to saturated fatty acids ratio | GCST90502593 | 11.26 |
| 1665 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T93 | ECGA000093 | 11.25 |
| 1666 | X-13548 levels | GCST90243821 | 11.25 |
| 1667 | Headaches for 3+ months | Pain | UKBB00000307 | 11.24 |
| 1668 | Panic attacks | Mental distress | UKBB00000634 | 11.24 |
| 1669 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T311 | ECGU000311 | 11.23 |
| 1670 | Other disorders of synovium, tendon, and bursa (PheCode 727) | GCST90476241 | 11.23 |
| 1671 | Glutamine levels | GCST90092818 | 11.20 |
| 1672 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T448 | ECGA000448 | 11.20 |
| 1673 | Waist-to-hip ratio adjusted for BMI | GCST90025996 | 11.19 |
| 1674 | Calcific aortic valve stenosis | GCST90310293 | 11.18 |
| 1675 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T259 | ECGU000259 | 11.17 |
| 1676 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T53 | ECGA000053 | 11.17 |
| 1677 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T74 | ECGU000074 | 11.16 |
| 1678 | Right ventricular ejection fraction | GCST90134591 | 11.16 |
| 1679 | COL4A1 levels | GCST90468818 | 11.16 |
| 1680 | PLAUR/PRSS8 ratio | GCST90315675 | 11.13 |
| 1681 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T82 | ECGU000082 | 11.13 |
| 1682 | Volume of right paralaminar nucleus | GCST90474928 | 11.11 |
| 1683 | Principal component-derived dietary pattern 2 | GCST90133007 | 11.11 |
| 1684 | Free Cholesterol to Total Lipids in Small VLDL percentage | GCST90499831 | 11.10 |
| 1685 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T246 | ECGA000246 | 11.10 |
| 1686 | X-24544 levels | GCST90200636 | 11.09 |
| 1687 | Free Cholesterol to Total Lipids in IDL percentage | GCST90497576 | 11.09 |
| 1688 | Phospholipids in small VLDL | GCST90499881 | 11.08 |
| 1689 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T1 | ECGU000001 | 11.08 |
| 1690 | Bone marrow fat fraction of lumbar vertebra 2 | GCST90652387 | 11.08 |
| 1691 | IDP dMRI TBSS FA Cingulum cingulate gyrus R | GCST90003911 | 11.08 |
| 1692 | IDP dMRI TBSS ISOVF External capsule R | GCST90004509 | 11.07 |
| 1693 | Arm fat mass (left) | Impedance measures | UKBB00000043 | 11.06 |
| 1694 | ADAMTS15/CLMP ratio | GCST90313170 | 11.06 |
| 1695 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T64 | ECGU000064 | 11.05 |
| 1696 | Alcohol use disorder, Swedish definition | FING00000053 | 11.04 |
| 1697 | aparc-a2009s rh area G-pariet-inf-Supramar | GCST90003396 | 11.04 |
| 1698 | DTI autoptx L3 ilf l tract | GCST90385207 | 11.04 |
| 1699 | IDP dMRI TBSS ICVF Superior corona radiata R | GCST90004351 | 11.04 |
| 1700 | DTI TBSS MD Sagittal stratum R | GCST90384602 | 11.03 |
| 1701 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T108 | ECGU000108 | 11.02 |
| 1702 | Fasciitis | musculoskeletal | UKBB00000239 | 11.01 |
| 1703 | CTSF/NAAA ratio | GCST90314314 | 11.00 |
| 1704 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T424 | ECGA000424 | 11.00 |
| 1705 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T332 | ECGU000332 | 10.99 |
| 1706 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T38 | ECGU000038 | 10.98 |
| 1707 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502043 | 10.98 |
| 1708 | Free cholesterol in large LDL | GCST90497981 | 10.98 |
| 1709 | IDP dMRI ProbtrackX L1 ifo r | GCST90004259 | 10.98 |
| 1710 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T294 | ECGU000294 | 10.97 |
| 1711 | IDP dMRI TBSS L1 Cerebral peduncle R | GCST90004089 | 10.97 |
| 1712 | ALDH1A1/CA3 ratio | GCST90313244 | 10.97 |
| 1713 | Non-cancer illness code, self-reported - type 2 diabetes | Medical conditions | UKBB00000522 | 10.97 |
| 1714 | Principal component-derived dietary pattern 20 | GCST90133025 | 10.95 |
| 1715 | BA-exvivo lh area BA3b | GCST90003210 | 10.95 |
| 1716 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T80 | ECGU000080 | 10.94 |
| 1717 | Linoleic acid to total fatty acids percentage | GCST90502320 | 10.94 |
| 1718 | Systolic blood pressure (standard GWA) | GCST90267304 | 10.92 |
| 1719 | Medical abortion | FING00000796 | 10.91 |
| 1720 | Cholesterol, total | GCST000760 | 10.90 |
| 1721 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T203 | ECGA000203 | 10.89 |
| 1722 | Cholesterol levels in very small VLDL | GCST90500712 | 10.89 |
| 1723 | Colorectal cancer (PheCode 153) | GCST008372 | 10.88 |
| 1724 | Polyunsaturated fatty acids to total fatty acids percentage (UKB data field 23453) | GCST90269550 | 10.87 |
| 1725 | CEACAM8/VNN2 ratio | GCST90314005 | 10.85 |
| 1726 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502049 | 10.85 |
| 1727 | FAM171B levels | GCST90469183 | 10.84 |
| 1728 | Central corneal thickness | GCST006366 | 10.84 |
| 1729 | Concentration of IDL particles | GCST90497614 | 10.83 |
| 1730 | Phospholipid levels in very large HDL | GCST90132642 | 10.82 |
| 1731 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T328 | ECGU000328 | 10.82 |
| 1732 | Prescriptions - lipase inhibitor|obesity | UKBB00000688 | 10.80 |
| 1733 | Prescriptions - orlistat | lipase inhibitor,obesity | UKBB00000695 | 10.80 |
| 1734 | Cardiorespiratory fitness slope | GCST90093319 | 10.79 |
| 1735 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T138 | ECGU000138 | 10.78 |
| 1736 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T335 | ECGU000335 | 10.78 |
| 1737 | Anxiety disorders (more control exclusions) | FING00000098 | 10.78 |
| 1738 | Spinal stenosis | FING00001322 | 10.77 |
| 1739 | FGFBP1 levels | GCST90469230 | 10.75 |
| 1740 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T338 | ECGU000338 | 10.75 |
| 1741 | SH2B3/TBL1X ratio | GCST90315841 | 10.73 |
| 1742 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T446 | ECGA000446 | 10.73 |
| 1743 | Polyneuropathy in diabetes (PheCode 250.6) | GCST90475686 | 10.73 |
| 1744 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 11) | GCST90320574 | 10.72 |
| 1745 | Hypopotassemia (PheCode 276.14) | GCST90475755 | 10.72 |
| 1746 | Cholesterol to Total Lipids in Large LDL percentage | GCST90497929 | 10.71 |
| 1747 | Lung cancer | GCST004748 | 10.70 |
| 1748 | PSPN levels | GCST90470364 | 10.70 |
| 1749 | Pulse pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000719 | 10.69 |
| 1750 | Pulse pressure, combined automated + manual reading | Cardiovascular measurement | UKBB00000718 | 10.68 |
| 1751 | ICAM5 levels | GCST90241541 | 10.66 |
| 1752 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T203 | ECGU000203 | 10.66 |
| 1753 | Polycystic ovarian syndrome | FING00001182 | 10.65 |
| 1754 | aparc-a2009s rh volume G-precentral | GCST90003027 | 10.64 |
| 1755 | Hearing (confirmatory factor analysis Factor 32) | GCST90309366 | 10.63 |
| 1756 | IDP dMRI TBSS ICVF Superior corona radiata L | GCST90004352 | 10.62 |
| 1757 | Fasting blood glucose | GCST005186 | 10.61 |
| 1758 | Free cholesterol to total lipids ratio in large LDL | GCST90092861 | 10.61 |
| 1759 | IDP dMRI TBSS L2 External capsule L | GCST90004156 | 10.61 |
| 1760 | Systolic blood pressure | GCST90301695 | 10.60 |
| 1761 | IDP dMRI TBSS L1 Posterior corona radiata R | GCST90004101 | 10.60 |
| 1762 | Systolic blood pressure, automated reading | Blood pressure | UKBB00000803 | 10.60 |
| 1763 | sodium (minimum, inv-norm transformed) | GCST90476397 | 10.60 |
| 1764 | BA-exvivo rh area BA3b | GCST90003224 | 10.60 |
| 1765 | Left ventricular end systole inferolateral wall thickness | GCST90278510 | 10.59 |
| 1766 | IDP dMRI ProbtrackX MD ar l | GCST90004219 | 10.56 |
| 1767 | T1 CAT volume L CingulateGyrusanteriordivision | GCST90384056 | 10.55 |
| 1768 | Saturated fatty acids levels | GCST90499950 | 10.53 |
| 1769 | LAT2/YES1 ratio | GCST90315282 | 10.53 |
| 1770 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T200 | ECGU000200 | 10.52 |
| 1771 | IDP dMRI ProbtrackX L2 cst r | GCST90004282 | 10.50 |
| 1772 | Salad leaves liking | GCST90094823 | 10.50 |
| 1773 | eGFR in diabetes mellitus (loose) kidney healthy controls (minimal adjustment) | GCST90624778 | 10.48 |
| 1774 | aparc-DKTatlas rh volume supramarginal | GCST90002922 | 10.48 |
| 1775 | IDP dMRI TBSS ICVF Inferior cerebellar peduncle R | GCST90004337 | 10.47 |
| 1776 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T283 | ECGA000283 | 10.46 |
| 1777 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T78 | ECGU000078 | 10.46 |
| 1778 | Brain glioblastoma, excluding all cancers (controls excluding all cancers) | FING00000225 | 10.46 |
| 1779 | DTI TBSS L1 Genu of corpus callosum | GCST90384430 | 10.45 |
| 1780 | DTI autoptx L2 slf r tract | GCST90385188 | 10.45 |
| 1781 | FETUB levels | GCST90469215 | 10.43 |
| 1782 | Heart failure | GCST009541 | 10.41 |
| 1783 | X-21353 metabolite level | GCST90616708 | 10.41 |
| 1784 | IL16 levels | GCST90241596 | 10.41 |
| 1785 | Glucose (fasting status unknown, mean, inv-norm transformed) | GCST90475332 | 10.40 |
| 1786 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T225 | ECGU000225 | 10.39 |
| 1787 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T421 | ECGA000421 | 10.39 |
| 1788 | Myocardial infarction, strict | FING00000852 | 10.39 |
| 1789 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T341 | ECGU000341 | 10.39 |
| 1790 | Tibia length to body height ratio | GCST90270258 | 10.38 |
| 1791 | Polyunsaturated fatty acids to total fatty acids percentage | GCST90502632 | 10.38 |
| 1792 | CLEC4A levels | GCST90468771 | 10.37 |
| 1793 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T6 | ECGU000006 | 10.37 |
| 1794 | F11 levels | GCST90469165 | 10.36 |
| 1795 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502373 | 10.36 |
| 1796 | Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000720 | 10.36 |
| 1797 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T308 | ECGA000308 | 10.35 |
| 1798 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T112 | ECGU000112 | 10.31 |
| 1799 | COMP levels | GCST90468827 | 10.30 |
| 1800 | IDP dMRI TBSS OD Genu of corpus callosum | GCST90004404 | 10.30 |
| 1801 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T237 | ECGA000237 | 10.29 |
| 1802 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T240 | ECGA000240 | 10.29 |
| 1803 | Aortic aneurysm | FING00000102 | 10.28 |
| 1804 | Right ventricular ejection fraction (MTAG) | GCST90134595 | 10.27 |
| 1805 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T55 | ECGU000055 | 10.26 |
| 1806 | Waist circumference | GCST90103753 | 10.26 |
| 1807 | Prolapse of vaginal walls | genitourinary | UKBB00000712 | 10.25 |
| 1808 | DTI TBSS L3 Superior longitudinal fasciculus R | GCST90384564 | 10.24 |
| 1809 | Concentration of small LDL particles | GCST90499669 | 10.24 |
| 1810 | Body mass index | GCST90428119 | 10.23 |
| 1811 | Hot drink temperature | Diet | UKBB00000329 | 10.22 |
| 1812 | Cholesterol in Medium LDL | GCST90498707 | 10.22 |
| 1813 | Fasting blood insulin | GCST005185 | 10.21 |
| 1814 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T320 | ECGA000320 | 10.21 |
| 1815 | CA1/TGM2 ratio | GCST90313575 | 10.21 |
| 1816 | Total testosterone levels | GCST90503313 | 10.20 |
| 1817 | Cholesteryl Esters to Total Lipids in Very Small VLDL percentage | GCST90500764 | 10.20 |
| 1818 | DSG3/DSG4 ratio | GCST90314558 | 10.18 |
| 1819 | KRT5 levels | GCST90469718 | 10.18 |
| 1820 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T368 | ECGU000368 | 10.18 |
| 1821 | Time to complete round | Pairs matching | UKBB00000822 | 10.18 |
| 1822 | Cholesteryl Esters in Medium VLDL | GCST90498939 | 10.18 |
| 1823 | Cereal type: Biscuit cereal (e.g. Weetabix) (UKB data field 1468_2) | GCST90132969 | 10.17 |
| 1824 | Corneal dystrophy (PheCode 364.5) | GCST90475864 | 10.17 |
| 1825 | IDP dMRI TBSS FA Sagittal stratum L | GCST90003908 | 10.16 |
| 1826 | IDP dMRI TBSS MD Posterior corona radiata L | GCST90004054 | 10.16 |
| 1827 | LDL cholesterol | GCST002222 | 10.15 |
| 1828 | Atrial fibrillation and flutter | FING00000126 | 10.15 |
| 1829 | GAST levels | GCST90469307 | 10.15 |
| 1830 | SNCA levels | GCST90240258 | 10.14 |
| 1831 | aparc-a2009s rh area S-central | GCST90003415 | 10.12 |
| 1832 | CPA2 levels | GCST90468837 | 10.12 |
| 1833 | PPIE levels | GCST90242217 | 10.12 |
| 1834 | Tea with sugar liking | GCST90094857 | 10.11 |
| 1835 | T1 CAT volume R RightAccumbens | GCST90384109 | 10.10 |
| 1836 | IDP T1 FAST ROIs L cerebellum IX | GCST90002584 | 10.10 |
| 1837 | Total esterified cholesterol levels | GCST90500034 | 10.09 |
| 1838 | Autoimmune hepatitis | GCST90018565 | 10.08 |
| 1839 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T204 | ECGA000204 | 10.07 |
| 1840 | DTI TBSS MD Cingulum cingulate gyrus R | GCST90384606 | 10.07 |
| 1841 | Total cholesterol levels | GCST90500022 | 10.06 |
| 1842 | Milk type used: Soy milk vs never have milk (UKB data field 1418) | GCST90132943 | 10.05 |
| 1843 | Right-hemisphere visual network to caudate white-matter structural connectivity | GCST90302782 | 10.05 |
| 1844 | Cholesteryl esters in very large VLDL | GCST90500552 | 10.04 |
| 1845 | Multi-trait sex score | GCST90270118 | 10.04 |
| 1846 | Platelet count | GCST90002358 | 10.04 |
| 1847 | wg lh intensity-contrast inferiorparietal | GCST90003799 | 10.04 |
| 1848 | Hearing difficulty/problems | Hearing | UKBB00000311 | 10.02 |
| 1849 | All anxiety disorders | FING00000059 | 10.01 |
| 1850 | Free cholesterol in small VLDL | GCST90499808 | 10.01 |
| 1851 | SLPI levels | GCST90426030 | 10.01 |
| 1852 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T202 | ECGU000202 | 10.01 |
| 1853 | Hypertension (confirmatory factor analysis Factor 12) | GCST90309346 | 9.99 |
| 1854 | Descending aorta diameter | GCST90267391 | 9.99 |
| 1855 | Saturated fatty acids to total fatty acids percentage | GCST90502697 | 9.99 |
| 1856 | Pulse pressure | GCST90301702 | 9.98 |
| 1857 | Arm fat mass (right) | Impedance measures | UKBB00000044 | 9.98 |
| 1858 | Bone marrow fat fraction of thoracic vertebra 8 | GCST90652380 | 9.96 |
| 1859 | Angina pectoris (PheCode 411.3) | GCST90475933 | 9.94 |
| 1860 | Pulse pressure, combined automated + manual reading, adjusted by medication | Cardiovascular measurement | UKBB00000721 | 9.94 |
| 1861 | HPCAL1/PMVK ratio | GCST90315076 | 9.94 |
| 1862 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T270 | ECGA000270 | 9.94 |
| 1863 | PDP1 levels | GCST90424296 | 9.92 |
| 1864 | IDP dMRI ProbtrackX FA ifo l | GCST90003937 | 9.92 |
| 1865 | Alcohol abuse, main dg (more control exclusions) | FING00000049 | 9.92 |
| 1866 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T247 | ECGA000247 | 9.91 |
| 1867 | Triglycerides in very small VLDL | GCST90500873 | 9.91 |
| 1868 | Number of days/week of moderate physical activity 10+ minutes | Physical activity | UKBB00000533 | 9.91 |
| 1869 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T277 | ECGA000277 | 9.90 |
| 1870 | Operation code - squint correction | Operations | UKBB00000566 | 9.89 |
| 1871 | Right-hemisphere somatomotor network to right-hemisphere salience/ventral attention network white-matter structural connectivity | GCST90302790 | 9.87 |
| 1872 | wg rh intensity-contrast parahippocampal | GCST90003842 | 9.87 |
| 1873 | Free cholesterol in very large VLDL | GCST90500575 | 9.87 |
| 1874 | Sources of admission to hospital (recoded) - Usual Place of residence | Summary Administration | UKBB00000786 | 9.86 |
| 1875 | Kiwi liking | GCST90094788 | 9.86 |
| 1876 | Cholesteryl ester_18:1_[M+NH4]1+ levels | GCST90060221 | 9.86 |
| 1877 | BACH1/EIF4G1 ratio | GCST90313438 | 9.84 |
| 1878 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T295 | ECGU000295 | 9.84 |
| 1879 | Linoleic acid levels | GCST90498309 | 9.83 |
| 1880 | Diverticulosis and diverticulitis (PheCode 562) | GCST90476073 | 9.82 |
| 1881 | Grapefruit liking | GCST90094774 | 9.82 |
| 1882 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T336 | ECGU000336 | 9.81 |
| 1883 | Other arthrosis | FING00000965 | 9.81 |
| 1884 | Edema (PheCode 782.3) | GCST90476272 | 9.81 |
| 1885 | CLUL1 levels | GCST90468792 | 9.80 |
| 1886 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T50 | ECGA000050 | 9.80 |
| 1887 | FAP/LRRN1 ratio | GCST90314783 | 9.79 |
| 1888 | Chronic airway obstruction (PheCode 496) | GCST90476027 | 9.79 |
| 1889 | Corneal opacity and other disorders of cornea (PheCode 364) | GCST90475861 | 9.78 |
| 1890 | Whole grain cereal liking | GCST90094869 | 9.78 |
| 1891 | IDP dMRI TBSS MD Inferior cerebellar peduncle R | GCST90004037 | 9.78 |
| 1892 | Joint pain (confirmatory factor analysis Factor 14) | GCST90309348 | 9.77 |
| 1893 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T154 | ECGU000154 | 9.76 |
| 1894 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T318 | ECGA000318 | 9.76 |
| 1895 | IDP dMRI TBSS L3 Superior fronto-occipital fasciculus R | GCST90004213 | 9.75 |
| 1896 | CD20 on IgD- CD24- B cell | GCST90001753 | 9.75 |
| 1897 | T1 brain MRIs Unsupervised Deep learning derived Imaging Phenotypes (dimension 14) | GCST90320577 | 9.74 |
| 1898 | Fracture of hand or wrist (PheCode 804) | GCST90476281 | 9.73 |
| 1899 | IDP dMRI TBSS L3 Splenium of corpus callosum | GCST90004175 | 9.73 |
| 1900 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T7 | ECGU000007 | 9.72 |
| 1901 | Fracture of lumbar spine and pelvis | FING00000556 | 9.71 |
| 1902 | End-diastolic bi-ventricular shape (principal component 3) | GCST90448482 | 9.71 |
| 1903 | Free Cholesterol to Total Lipids in Large LDL percentage | GCST90498007 | 9.69 |
| 1904 | Left ventricular mass (indexed to body surface area) | GCST90435260 | 9.69 |
| 1905 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T199 | ECGU000199 | 9.68 |
| 1906 | Mean arterial pressure, automated reading | Cardiovascular measurement | UKBB00000434 | 9.68 |
| 1907 | IDP dMRI TBSS ICVF External capsule R | GCST90004359 | 9.68 |
| 1908 | Free cholesterol to total lipids in large LDL percentage (UKB data field 23617) | GCST90269714 | 9.68 |
| 1909 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T196 | ECGU000196 | 9.68 |
| 1910 | Intelligence | GCST006250 | 9.68 |
| 1911 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T299 | ECGU000299 | 9.67 |
| 1912 | CHRDL1 levels | GCST90468750 | 9.66 |
| 1913 | IDP dMRI TBSS L3 Superior longitudinal fasciculus L | GCST90004212 | 9.64 |
| 1914 | FSTL3/LTBR ratio | GCST90314883 | 9.64 |
| 1915 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T415 | ECGU000415 | 9.64 |
| 1916 | Depression or dysthymia | FING00000400 | 9.64 |
| 1917 | IDP dMRI TBSS MO Cerebral peduncle L | GCST90003967 | 9.63 |
| 1918 | IDP dMRI TBSS L3 Anterior limb of internal capsule R | GCST90004187 | 9.63 |
| 1919 | Personal history of medical treatment | Persons with potential health hazards related to family and personal history and certain conditions influencing health status | UKBB00000643 | 9.63 |
| 1920 | CAPN3 levels | GCST90468538 | 9.63 |
| 1921 | Polyarthrosis | FING00001181 | 9.62 |
| 1922 | MMP3 levels | GCST90469920 | 9.61 |
| 1923 | ALDH1A1/PKLR ratio | GCST90313245 | 9.60 |
| 1924 | NEFL levels | GCST90470024 | 9.59 |
| 1925 | IDP dMRI ProbtrackX OD slf r | GCST90004472 | 9.58 |
| 1926 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T44 | ECGU000044 | 9.58 |
| 1927 | Phospholipids to Total Lipids in Medium LDL percentage | GCST90498847 | 9.58 |
| 1928 | IDP dMRI ProbtrackX FA str r | GCST90003949 | 9.58 |
| 1929 | Cholesteryl Esters to Total Lipids in Small LDL percentage | GCST90499602 | 9.58 |
| 1930 | Hallux valgus (acquired) | FING00000601 | 9.57 |
| 1931 | rfMRI connectivity (ICA100 edge 912) | GCST90005765 | 9.56 |
| 1932 | Monounsaturated fatty acid levels | GCST90502030 | 9.56 |
| 1933 | Weight, inverse-rank normalized | FING00001447 | 9.56 |
| 1934 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T208 | ECGU000208 | 9.55 |
| 1935 | Usual side of head for mobile phone use - Left | Electronic device use | UKBB00000889 | 9.54 |
| 1936 | Bitter ale liking | GCST90094705 | 9.54 |
| 1937 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T304 | ECGA000304 | 9.53 |
| 1938 | LY6D/PLA2G10 ratio | GCST90315345 | 9.53 |
| 1939 | APOM/MCAM ratio | GCST90313315 | 9.52 |
| 1940 | DTI autoptx L3 str r tract | GCST90385217 | 9.51 |
| 1941 | Triglycerides to total lipids ratio in very large VLDL | GCST90093027 | 9.49 |
| 1942 | IDP dMRI ProbtrackX L2 ifo l | GCST90004285 | 9.49 |
| 1943 | Unstable angina pectoris | GCST90018712 | 9.48 |
| 1944 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T258 | ECGU000258 | 9.47 |
| 1945 | HippSubfield lh volume CA3-body | GCST90002680 | 9.47 |
| 1946 | Number in household | Household | UKBB00000530 | 9.47 |
| 1947 | Monounsaturated fatty acids to total fatty acids percentage | GCST90502372 | 9.45 |
| 1948 | Main speciality of consultant (recoded) - Anaesthetics | Summary Administration | UKBB00000413 | 9.45 |
| 1949 | Hyperglyceridemia (PheCode 272.12) | GCST90475724 | 9.45 |
| 1950 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T212 | ECGU000212 | 9.44 |
| 1951 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T63 | ECGU000063 | 9.44 |
| 1952 | IDP dMRI TBSS MD Superior longitudinal fasciculus L | GCST90004068 | 9.43 |
| 1953 | Cholesterol to Total Lipids in Medium LDL percentage | GCST90498723 | 9.43 |
| 1954 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T124 | ECGA000124 | 9.43 |
| 1955 | CEACAM1/GGT1 ratio | GCST90314000 | 9.43 |
| 1956 | ThalamNuclei rh volume VLp | GCST90002755 | 9.42 |
| 1957 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T420 | ECGA000420 | 9.42 |
| 1958 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T292 | ECGA000292 | 9.41 |
| 1959 | DTI autoptx MD slf r tract | GCST90385242 | 9.40 |
| 1960 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T285 | ECGA000285 | 9.38 |
| 1961 | IDP dMRI TBSS L3 Posterior thalamic radiation R | GCST90004199 | 9.37 |
| 1962 | Tiglylcarnitine (C5:1-DC) levels | GCST90199800 | 9.37 |
| 1963 | STROKE | FING00001336 | 9.36 |
| 1964 | Hearing difficulty/problems | Hearing | UKBB00000310 | 9.36 |
| 1965 | IDP dMRI TBSS L2 Inferior cerebellar peduncle R | GCST90004133 | 9.36 |
| 1966 | PSAPL1 levels | GCST90470350 | 9.36 |
| 1967 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T327 | ECGU000327 | 9.34 |
| 1968 | T1 FreeSurfer aseg Left-Lateral-Ventricle | GCST90384139 | 9.34 |
| 1969 | BAP18 levels | GCST90468422 | 9.34 |
| 1970 | Biliverdin levels in chronic kidney disease | GCST90257495 | 9.33 |
| 1971 | Other dyspnea (PheCode 512.9) | GCST90476042 | 9.33 |
| 1972 | Free Cholesterol to Total Lipids in Medium VLDL percentage | GCST90498976 | 9.32 |
| 1973 | MCAM levels | GCST90469870 | 9.31 |
| 1974 | Omega-6 fatty acids to total fatty acids percentage | GCST90502545 | 9.31 |
| 1975 | Cholesterol in Medium VLDL | GCST90498903 | 9.30 |
| 1976 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T122 | ECGA000122 | 9.30 |
| 1977 | Concentration of medium LDL particles | GCST90498823 | 9.29 |
| 1978 | Hippocampal subfield left CA4 volume (head) | GCST90267943 | 9.29 |
| 1979 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T201 | ECGA000201 | 9.28 |
| 1980 | High-grade serous epithelial ovarian cancer | GCST90244168 | 9.27 |
| 1981 | CHMP1A levels | GCST90619002 | 9.26 |
| 1982 | IDP dMRI ProbtrackX OD fma | GCST90004460 | 9.25 |
| 1983 | ENO2/RWDD1 ratio | GCST90314667 | 9.25 |
| 1984 | rfMRI amplitudes (ICA25 node 14) | GCST90004581 | 9.25 |
| 1985 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T334 | ECGU000334 | 9.24 |
| 1986 | Free cholesterol in small LDL | GCST90499617 | 9.23 |
| 1987 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T422 | ECGA000422 | 9.23 |
| 1988 | Hip circumference | Body size measures | UKBB00000328 | 9.22 |
| 1989 | IDP dMRI ProbtrackX ICVF cst l | GCST90004383 | 9.22 |
| 1990 | IDP dMRI TBSS L3 Retrolenticular part of internal capsule R | GCST90004191 | 9.22 |
| 1991 | Left-hemisphere default mode network to left-hemisphere default mode network white-matter structural connectivity | GCST90302759 | 9.21 |
| 1992 | Electrocardiogram morphology (amplitude at temporal datapoints) unadjusted, T134 | ECGU000134 | 9.20 |
| 1993 | Polyunsaturated fatty acids to monounsaturated fatty acids ratio | GCST90502155 | 9.20 |
| 1994 | IDP dMRI TBSS ICVF Tapetum L | GCST90004374 | 9.19 |
| 1995 | IDP dMRI TBSS L2 Posterior limb of internal capsule L | GCST90004142 | 9.19 |
| 1996 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T288 | ECGA000288 | 9.18 |
| 1997 | Solitary pulmonary nodule (PheCode 514.2) | GCST90476044 | 9.16 |
| 1998 | Viral haemorrhagic fevers, not elsewhere classified/unspecified | FING00001433 | 9.16 |
| 1999 | Electrocardiogram morphology (amplitude at temporal datapoints) adjusted, T319 | ECGA000319 | 9.16 |
| 2000 | Prescriptions - opioid analgesic|selective serotonin re-uptake inhibitor|norepinephrine re-uptake inhibitor | UKBB00000694 | 9.15 |